<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2023.1213956</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Erratum</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Erratum: Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Production Office</collab>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/20170/overview"/>
</contrib>
</contrib-group>
<aff><institution>Frontiers Media SA</institution>, <addr-line>Lausanne</addr-line>, <country>Switzerland</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Frontiers Production Office <email>production.office&#x00040;frontiersin.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1213956</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 Frontiers Production Office.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Frontiers Production Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license></permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Neurol." journal-id-type="nlm-ta" vol="13" page="830057" xlink:href="10.3389/fneur.2022.830057" ext-link-type="doi">An Erratum on <article-title>Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children)</article-title> by Kozik, V., Schwab, M., Thiel, S., Hellwig, K., Rakers, F., and Dreiling, M. (2022). <italic>Front. Neurol</italic>. 13:830057. doi: <object-id>10.3389/fneur.2022.830057</object-id></related-article>
<kwd-group>
<kwd>multiple sclerosis</kwd>
<kwd>glucocorticoids</kwd>
<kwd>methylprednisolone</kwd>
<kwd>cognition</kwd>
<kwd>pituitary-adrenal axis</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
<word-count count="358"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Multiple Sclerosis and Neuroimmunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Due to a production error, the reference for &#x0201C;11&#x0201D; was incorrectly written as &#x0201C;Li C, Kaiyu L, Sooranna SR, Bennett PR., Zinging L, Dimitris G, et al. The effect of cAMP on PRE promoter activity in presence or absence of progesterone. In: <italic>57th Annual Meeting of the Society for Gynecologic Investigation</italic>, Vol.17. Orlando, FL: Reproductive Sciences (2010). doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/193371912010173s067">10.1177/193371912010173s067</ext-link>&#x0201D;. It should be &#x0201C;Rakers F, Schleu&#x000DF;ner E, Muth I, Hoyer D, Rupprecht S, Schiecke K, et al. Impact of antenatal glucocorticoid exposure on activity of the stress system, cognition and behavior in 8&#x02013;9-year-old children: a clinical cohort study. (in preparation).&#x0201D;</p>
<p>The publisher apologizes for this mistake. The original article has been updated.</p>
</body>
</article>